AR025867A1 - PHARMACEUTICAL PORTASDORA FORMULATION - Google Patents
PHARMACEUTICAL PORTASDORA FORMULATIONInfo
- Publication number
- AR025867A1 AR025867A1 ARP000105037A ARP000105037A AR025867A1 AR 025867 A1 AR025867 A1 AR 025867A1 AR P000105037 A ARP000105037 A AR P000105037A AR P000105037 A ARP000105037 A AR P000105037A AR 025867 A1 AR025867 A1 AR 025867A1
- Authority
- AR
- Argentina
- Prior art keywords
- portasdora
- formulation
- pharmaceutical
- portasdora formulation
- pharmaceutical portasdora
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40616499A | 1999-09-27 | 1999-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR025867A1 true AR025867A1 (en) | 2002-12-18 |
Family
ID=23606801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105037A AR025867A1 (en) | 1999-09-27 | 2000-09-26 | PHARMACEUTICAL PORTASDORA FORMULATION |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1216029A1 (en) |
JP (1) | JP2003510267A (en) |
KR (1) | KR20020064289A (en) |
CN (1) | CN1399542A (en) |
AR (1) | AR025867A1 (en) |
AU (1) | AU7716100A (en) |
BR (1) | BR0014308A (en) |
CA (1) | CA2388471A1 (en) |
CZ (1) | CZ20021082A3 (en) |
EA (1) | EA200200415A1 (en) |
HK (1) | HK1044485A1 (en) |
HU (1) | HUP0202652A3 (en) |
IL (1) | IL148543A0 (en) |
MX (1) | MXPA02003190A (en) |
NO (1) | NO20021476L (en) |
PL (1) | PL354331A1 (en) |
WO (1) | WO2001022942A1 (en) |
ZA (1) | ZA200203311B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US20030105144A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
JPWO2004073692A1 (en) * | 2003-02-18 | 2006-06-01 | 山下 伸二 | Hard capsule of poorly water-soluble drug |
CN100342856C (en) * | 2003-04-10 | 2007-10-17 | 上海医药工业研究院 | Composition of danazol semisolid skeleton preparation |
JP5406529B2 (en) | 2005-10-26 | 2014-02-05 | バナー ファーマキャプス, インコーポレイテッド | Dual controlled release matrix system based on lipophilic vehicle as capsule filler |
CN101360485B (en) * | 2005-10-26 | 2013-04-17 | 班纳制药公司 | Hydrophilic vehicle-based dual controlled release matrix system |
US20100093725A1 (en) * | 2006-10-31 | 2010-04-15 | Wyeth | Semi-solid formulations of phospholipase enzyme inhibitors |
ES2944116T3 (en) * | 2017-12-20 | 2023-06-19 | Firmenich & Cie | Oral care compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3636123A1 (en) * | 1986-10-23 | 1988-05-05 | Rentschler Arzneimittel | ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE |
US5599808A (en) * | 1994-02-18 | 1997-02-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
ATE429210T1 (en) * | 1998-01-20 | 2009-05-15 | Applied Analytical Ind Inc | ORAL LIQUID COMPOSITIONS |
-
2000
- 2000-09-26 KR KR1020027003934A patent/KR20020064289A/en not_active Application Discontinuation
- 2000-09-26 EA EA200200415A patent/EA200200415A1/en unknown
- 2000-09-26 CA CA002388471A patent/CA2388471A1/en not_active Abandoned
- 2000-09-26 HU HU0202652A patent/HUP0202652A3/en unknown
- 2000-09-26 CN CN00816307A patent/CN1399542A/en active Pending
- 2000-09-26 PL PL00354331A patent/PL354331A1/en not_active Application Discontinuation
- 2000-09-26 MX MXPA02003190A patent/MXPA02003190A/en unknown
- 2000-09-26 BR BR0014308-1A patent/BR0014308A/en not_active Application Discontinuation
- 2000-09-26 WO PCT/US2000/026381 patent/WO2001022942A1/en not_active Application Discontinuation
- 2000-09-26 AU AU77161/00A patent/AU7716100A/en not_active Abandoned
- 2000-09-26 IL IL14854300A patent/IL148543A0/en unknown
- 2000-09-26 EP EP00966880A patent/EP1216029A1/en not_active Withdrawn
- 2000-09-26 CZ CZ20021082A patent/CZ20021082A3/en unknown
- 2000-09-26 AR ARP000105037A patent/AR025867A1/en unknown
- 2000-09-26 JP JP2001526154A patent/JP2003510267A/en active Pending
-
2002
- 2002-03-25 NO NO20021476A patent/NO20021476L/en not_active Application Discontinuation
- 2002-04-25 ZA ZA200203311A patent/ZA200203311B/en unknown
- 2002-08-23 HK HK02106196.7A patent/HK1044485A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20021082A3 (en) | 2002-06-12 |
MXPA02003190A (en) | 2002-09-30 |
ZA200203311B (en) | 2003-12-31 |
EA200200415A1 (en) | 2002-10-31 |
BR0014308A (en) | 2002-05-21 |
KR20020064289A (en) | 2002-08-07 |
JP2003510267A (en) | 2003-03-18 |
AU7716100A (en) | 2001-04-30 |
EP1216029A1 (en) | 2002-06-26 |
PL354331A1 (en) | 2004-01-12 |
IL148543A0 (en) | 2002-09-12 |
HUP0202652A2 (en) | 2004-05-28 |
NO20021476D0 (en) | 2002-03-25 |
HK1044485A1 (en) | 2002-10-25 |
CN1399542A (en) | 2003-02-26 |
HUP0202652A3 (en) | 2004-06-28 |
WO2001022942A1 (en) | 2001-04-05 |
CA2388471A1 (en) | 2001-04-05 |
NO20021476L (en) | 2002-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITTO20010008A0 (en) | PHARMACEUTICAL FORMULATION | |
NO20015175D0 (en) | Pharmaceutical composition | |
PT1242087E (en) | PHARMACEUTICAL COMPOSITIONS | |
NO992339D0 (en) | Pharmaceutical Formulations | |
ID24654A (en) | OMEPRAZOLA PHARMACEUTICAL FORMULATION | |
FI991485A0 (en) | New pharmaceutical composition | |
NO20033384L (en) | Pharmaceutical Formulation | |
FIU20000164U0 (en) | A new pharmaceutical formulation | |
NO20020086L (en) | Flavor-masked pharmaceutical liquid formulations | |
NO20033785L (en) | Pharmaceutical formulation | |
NO20015670L (en) | Improved pharmaceutical formulations | |
NO20035627D0 (en) | Pharmaceutical formulation | |
NO20022606L (en) | Pharmaceutical combinations | |
PT1239832E (en) | PHARMACEUTICAL COMPOSITIONS | |
NO20014926L (en) | Pharmaceutical compounds | |
ID30032A (en) | PHARMACEUTICAL FORMULATION | |
FI4488U1 (en) | Pharmaceutical composition | |
DK1227817T3 (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
AR025867A1 (en) | PHARMACEUTICAL PORTASDORA FORMULATION | |
EE200100697A (en) | Pharmaceutical complex | |
NO20004816D0 (en) | New pharmaceutical formulation | |
NO20021036L (en) | Pharmaceutical preparation | |
SE9803952D0 (en) | Pharmaceutical formulation | |
NO20041236L (en) | Pharmaceutical Formulation | |
SE9901967D0 (en) | New solid dosage formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |